Company 21st North Inc OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
2016 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
2015 | Urologix Conducting A Strategic Review | CI |
Business Summary
Sales per Business
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
Medical Products
100.0
%
| 17 | 100.0 % | 14 | 100.0 % | -14.20% |
Sales per region
USD in Million | 2013 | Weight | 2014 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 17 | 100.0 % | 14 | 100.0 % | -14.20% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 91-05-28 |
Scott Madson
DFI | Director of Finance/CFO | 63 | 15-03-31 |
Lisa Ackermann
SAM | Sales & Marketing | 51 | 11-06-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 91-05-28 |
Sidney Emery
BRD | Director/Board Member | 74 | 05-09-30 |
Director/Board Member | 57 | 10-08-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,817,726 | 21,817,726 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Urologix, Inc.
14405 21st Avenue North
55447-4699, Minneapolis
+
Sector
1st Jan change | Capi. | |
---|---|---|
+8.33% | 217B | |
+6.72% | 183B | |
+10.18% | 131B | |
+24.91% | 106B | |
-0.95% | 62.16B | |
+10.56% | 51.02B | |
+4.81% | 50.89B | |
-0.24% | 40.16B | |
+1.22% | 34.79B |
- Stock Market
- Equities
- ULGX Stock
- Stock
- Company 21st North Inc